Elevance Health (NYSE: ELV) Q4 2024 Earnings Call Jan 23, 2025, 8:30 a.m. ET ...
Financial writer recommends buying Elevance Health stock despite recent drop, citing strong industry trends and potential for ...
Elevance Health Inc. (ELV), while reporting weak fourth-quarter earnings below market estimates, on Thursday issued fiscal 2025 ...
Reports Q4 revenue $45B, consensus $44.72B. “As part of our commitment to elevating whole health and advancing health beyond healthcare, we ...
For the year, the company reported profit of $5.98 billion, or $25.68 per share. Revenue was reported as $175.2 billion. Elevance Health expects full-year earnings in the range of $34.15 to $34.85 per ...
Elevance Health posted $418 million in profit for the fourth quarter of 2024, a figure that surpassed Wall Street's ...
The company posted adjusted earnings per share of $3.84 for Q4 2024, falling short of the $3.98 consensus estimate. Revenue ...
Elevance Health, Inc. ELV reported fourth-quarter 2024 adjusted earnings per share (EPS) of $3.84, which surpassed the Zacks Consensus Estimate by 1.1%. However, the bottom line deteriorated 31.7% ...
ELV's fourth-quarter earnings are likely to have benefited from growing premiums, partially offset by higher expenses.
Elevance Health (ELV) came out with quarterly earnings of $3.84 per share, beating the Zacks Consensus Estimate of $3.80 per share. This compares to earnings of $5.62 per share a year ago. These ...